Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. The Christie NHS Foundation Trust

Claim This Site

Are you the site administrator? Claim this site to update information.

Basic Information

Site Overview

Source: Google.

We are the largest single site cancer centre in Europe, treating more than 60,000 patients a year. We are also the first UK centre to be officially accredited as a comprehensive cancer centre. As part of the NHS we provide: Radiotherapy, in one of the world's largest radiotherapy departments and at our radiotherapy centres in Oldham, Salford and Macclesfield. We are also home to the UK’s largest brachytherapy service and we are also the first NHS organisation in the UK to deliver high energy proton beam therapy. Chemotherapy, in the UK's largest chemotherapy unit, as well as via 13 other sites and in patients’ homes. Highly specialist surgery for complex and rare cancer. A wide range of support and diagnostic services.

Business Status

Source: Google. OPEN

Business Category

Source: Google. Cancer treatment center

Business Subcategory

Source: Google. Cancer treatment center
Source: Google. Research institute
Source: Trial-derived.
385Total Trials
Source: Trial-derived.
84Recruiting Trials
Source: Trial-derived.
189Active Trials
Source: Trial-derived.
143Completed Trials
Source: Trial-derived.
497Unique Conditions
Source: Trial-derived.
287Unique Sponsors

Conditions

Source: Trial-derived. Breast Cancer (20)Source: Trial-derived. Cancer (17)Source: Trial-derived. Ovarian Cancer (13)Source: Trial-derived. Melanoma (12)Source: Trial-derived. Renal Cell Carcinoma (12)Source: Trial-derived. Multiple Myeloma (11)Source: Trial-derived. Neoplasms (11)Source: Trial-derived. Metastatic Breast Cancer (10)

Sponsors

Source: Trial-derived. Hoffmann-La Roche (58)Source: Trial-derived. Cancer Research UK (38)Source: Trial-derived. Merck Sharp & Dohme LLC (32)Source: Trial-derived. The Christie NHS Foundation Trust (27)Source: Trial-derived. University College, London (24)Source: Trial-derived. University of Manchester (21)Source: Trial-derived. AbbVie (19)Source: Trial-derived. AstraZeneca (18)

Facilities & Operations

Facilities and operational capabilities inferred from trial participation

Source: AI-inferred. Overnight or inpatient research stays supported

Research Technology

Research technology inferred from trial participation

Source: AI-inferred. Electronic data capture
Source: AI-inferred. Telehealth study visits

Imaging & Diagnostics

Imaging and diagnostic capabilities inferred from trial participation

Source: AI-inferred. Electrocardiography (lead count not stated)
Source: AI-inferred. CT Scan
Source: AI-inferred. 12-lead ECG
Source: AI-inferred. PET-CT
Source: AI-inferred. MRI

Laboratory & Biospecimens

Laboratory and biospecimen capabilities inferred from trial participation

Source: AI-inferred. Clinical laboratory testing
Source: AI-inferred. Timed pharmacokinetic sampling and processing
Source: AI-inferred. Specimen packaging and shipment
Source: AI-inferred. Histology / pathology
Source: AI-inferred. Immunogenicity (anti-drug antibody) testing
Source: AI-inferred. PCR / molecular
Source: AI-inferred. Pharmacokinetic bioanalysis

Research Pharmacy & Investigational Product

Investigational-product capabilities inferred from trial participation

Source: AI-inferred. Hazardous / cytotoxic drug handling
Source: AI-inferred. Sterile preparation (laminar-flow hood / BSC or cleanroom)

Clinical Procedures

Clinical procedures inferred from trial participation

Source: AI-inferred. Intravenous infusion administration
Source: AI-inferred. Tumour tissue biopsy (guidance not stated)
Source: AI-inferred. Bone marrow biopsy
Source: AI-inferred. Intensity-modulated radiation therapy
Source: AI-inferred. Lumbar puncture
Source: AI-inferred. Radiation therapy
Source: AI-inferred. Surgery / operating room

Accessibility & Parking

Accessibility Features

Source: Google. Wheelchair accessible entrance
Source: Google. Wheelchair accessible parking lot
Source: Google. Wheelchair accessible restroom

Amenities

Amenities Available

Source: Google. Restroom

Additional Capabilities

Other capabilities inferred from trial participation

Source: AI-inferred. Left ventricular ejection fraction assessment
Source: AI-inferred. Minimal residual disease (MRD) testing
Source: AI-inferred. Diagnostic radiologic imaging
Source: AI-inferred. Immunohistochemistry (IHC) biomarker testing
Source: AI-inferred. Left ventricular ejection fraction measurement
Source: AI-inferred. Lymphocyte subset enumeration
Source: AI-inferred. Ophthalmologic examination
Source: AI-inferred. PIK3CA mutation testing of tumour tissue